Rating scales

The BPRS (Brief Psychiatric Rating Scale)

April 17, 2026 9 min read

The Brief Psychiatric Rating Scale (BPRS) was published by John Overall and Donald Gorham in 1962 — making it older than every clinician currently using it. Its longevity comes from a simple combination: it is short enough to use in a busy clinic, broad enough to capture most of the symptoms that matter, and well enough validated that researchers know how to interpret what it produces. The original 18-item version is the most widely used; the expanded 24-item BPRS-E (Lukoff, Nuechterlein, and Ventura) added items that improved coverage of negative and disorganised symptoms.

In one sentence

The BPRS is an 18- or 24-item clinician-rated scale assessing a broad range of psychiatric symptoms — from anxiety and depression through hallucinations, delusions, hostility, and motor disturbance — each rated on a 1–7 severity scale.

Structure

The original 18 items cover:

The expanded BPRS-E adds bizarre behaviour, self-neglect, suicidality, elevated mood, distractibility, motor hyperactivity, and a few clarifying items. Each item is rated 1 (not present) to 7 (extremely severe), based on a brief interview and behavioural observation.

Subscales

Several factor-analytic models exist; the most common partition the BPRS into:

How it is administered

A BPRS interview takes 20 to 30 minutes for a trained rater — substantially shorter than the PANSS. It is semi-structured: the rater follows a recommended sequence of probes but can adapt phrasing. Items can be rated based on patient self-report, clinician observation during the interview, and (for some items, like motor retardation) behaviour over the previous week.

How scores are interpreted

The BPRS-18 has a possible range of 18 (every item "not present") to 126 (every item extreme). Common thresholds:

As with the PANSS, the field often defines clinical response as a 25–30% reduction from baseline.

Where the BPRS earns its keep

Strengths

Limitations

BPRS in context

If you read schizophrenia research from the 1970s and 1980s, you will see the BPRS everywhere. The PANSS arrived in 1987 and gradually displaced it for industry trials, but the BPRS never really left. It is still the right tool when you need a quick, validated picture of the major symptom domains — for example, in primary care psychiatry, training contexts, and naturalistic studies. Several large American research consortia, including some early-psychosis networks coordinated by NIMH, still use the BPRS-E.

What this means for patients and families

The BPRS is one of the most likely scales to show up in a real outpatient chart. If your clinician mentions a "BPRS score of 37," they are saying you are roughly in the mild-to-moderate range overall, with the specific item scores telling them which symptoms are driving the total. Asking which items are highest is a reasonable conversation starter, particularly if you are tracking change between visits.

How Frida thinks about it

For our daily self-report items we look at BPRS subscales as one of the construct anchors. Daily self-tracking and a clinician-administered BPRS at quarterly visits give complementary information — the BPRS sets the baseline, daily tracking finds the wobbles between visits.


This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.

Frequently asked questions

Is the BPRS still used in modern trials?
Yes, particularly in first-episode psychosis programs, naturalistic studies, and some smaller pharmaceutical trials. Industry phase 3 trials usually use the PANSS instead.
What is the difference between BPRS-18 and BPRS-E?
The BPRS-E (Expanded) by Lukoff, Nuechterlein, and Ventura adds 6 items, refines anchor descriptions, and improves coverage of negative and disorganised symptoms. It is the version most commonly used today.
Can the BPRS be used for non-schizophrenia conditions?
Yes — it was designed as a general psychiatric rating scale and has been used in mood disorders, dementia with behavioural disturbance, and other conditions. Its validity is strongest for psychotic and severe psychiatric symptoms.

Try Frida — your calm companion

Frida helps people living with schizophrenia track moods, manage medication, and build stability. 7-day free trial.

Get the app →